Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UMAN BIG/IMMUNOHBs for prevention of hepatitis B in newborns of HBV-carrier mothers
2010-021473-36Phase 4Terminated
- Sponsor
- Kedrion Biopharma
- Start
- Mar 2012
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of hepatitis B immunoglobulin in hepatitis B (HBV), sponsored by Kedrion Biopharma. Started Mar 2012; status: terminated.
02
Drugs
hepatitis B immunoglobulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on 2010-021473-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021473-36.